Sheila Ranganath

Sheila Ranganath

Private Equity Investor at
Flagship Pioneering, Inc.
Health Technology
Consumer Services
Finance

Profile

Sheila Ranganath is Senior Vice President at Flagship Pioneering, Inc. since 2024.
Formerly, Dr. Ranganath was Vice President- Biology at LifeMine Therapeutics, Inc. from 2021 to 2022, Director at Merck & Co., Inc. from 2019 to 2021, Director at Enumeral Biomedical Holdings, Inc. in 2016, and Principal at Pfizer Inc. in 2011.
Education includes a doctorate from the University of Washington and an undergraduate degree from the University of California.

Sheila Ranganath active positions

CompaniesPositionStart
Private Equity Investor 31/03/2022

Former positions of Sheila Ranganath

CompaniesPositionEnd
Private Equity Investor 01/03/2022
MERCK & CO., INC. Private Equity Investor 01/04/2021
ENUMERAL BIOMEDICAL HOLDINGS INC Private Equity Investor 01/08/2016
PFIZER INC. Corporate Officer/Principal 01/04/2011
See the detail of Sheila Ranganath's experience

Training of Sheila Ranganath

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

47

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Sheila Ranganath
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!